Freemont Management’s Thermo Fisher Scientific TMO Stock Holding History

Freemont Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,500	Closed	-$2.24M	–	112
2025 Q1	$2.24M	Buy	4,500 +2,900	+181%	+$1.57M	0.74%	47
2024 Q4	$832K	Hold	1,600	–	–	0.36%	71
2024 Q3	$990K	Hold	1,600	–	–	0.48%	63
2024 Q2	$885K	Sell	1,600 -7,900	-83%	-$4.53M	0.42%	56
2024 Q1	$5.52M	Sell	9,500 -3,000	-24%	-$1.68M	0.79%	44
2023 Q4	$6.63M	Hold	12,500	–	–	0.83%	40
2023 Q3	$6.33M	Sell	12,500 -2,100	-14%	-$1.12M	0.94%	38
2023 Q2	$7.62M	Hold	14,600	–	–	0.92%	37
2023 Q1	$8.42M	Hold	14,600	–	–	1.18%	32
2022 Q4	$8.04M	Hold	14,600	–	–	1.26%	27
2022 Q3	$7.41M	Sell	14,600 -1,234	-8%	-$691K	1.35%	23
2022 Q2	$8.6M	Buy	15,834 +34	+0.2%	+$18.7K	1.49%	20
2022 Q1	$9.33M	Buy	+15,800	New	+$9.08M	1.41%	20
2021 Q4	–	Sell	-22,900	Closed	-$13.1M	–	112
2021 Q3	$13.1M	Buy	22,900 +100	+0.4%	+$54.9K	1.73%	15
2021 Q2	$11.5M	Hold	22,800	–	–	1.65%	14
2021 Q1	$10.4M	Hold	22,800	–	–	1.7%	19
2020 Q4	$10.6M	Buy	+22,800	New	+$10.7M	1.98%	16

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Freemont Management's TMO Position: Q2 2025 in Review

Freemont Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 4,500 shares — an estimated $2.24M sold.

Freemont Management first reported a position in TMO in Q4 2020 and held it in 17 quarters. The position peaked at $13.1M in Q3 2021. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Freemont Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Freemont Management sold 4,500 Thermo Fisher Scientific shares in Q2 2025, an estimated $2.24M.
Freemont Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 17 quarters.
Freemont Management's Thermo Fisher Scientific position peaked at $13.1M in Q3 2021.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Freemont Management's 13F filing for Q2 2025, filed 7 Aug 2025.